-
-
-
-
-
-
-
InnovAge Announces Financial Results for the Fiscal First Quarter Ended September 30, 2024
-
-
-
-
-
-
-
InnovAge Announces Financial Results for the Fiscal Year and Fourth Quarter Ended June 30, 2022
-
-
-
-
-
-
-
InnovAge Announces Financial Results for the Fiscal Second Quarter Ended December 31, 2021
-
-
-
-
-
-
-
Aytu BioScience and Innovus Pharmaceuticals Announce Effectiveness of Form S-4 Registration Statement Related to Proposed Acquisition of Innovus by Aytu BioScience
-
-
-
-
-
-
-
Innovus Pharma Expands International Distribution by Signing an Exclusive Agreement in Peru with Pharma Solutions for Zestra®, Zestra Glide®, EjectDelay® and Sensum+®
-
-
-
-
-
-
-
SECFilings.com Covers Innovus Pharmaceuticals' Upcoming FDA Decision, Robust Portfolio, and Improved Cash Reserves and Financials
-
-
-
-
-
-
-
Innovus Pharmaceuticals Announces the Closing of the Acquisition of All of Beyond Human, LLCs Products Which Generated Over $2.2 Million in Sales in 2015
-
1,154,895 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

